1 report

In this trial, ## patients were randomized to receive one of three treatments: ## mg ITI-##, ## mg ITI-##, or placebo in a ##:##:## ratio.

  • Immunohaematology
  • In Vitro Diagnostic Reagent
  • Point Of Care Testing
  • Western Europe
  • Novartis AG